INH: Waxay Kaa Difaacaysaa Tiibayda[INH: Standing Between You and Tuberculosis]
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This report was conducted to systematically investigate the conditions under which Ultraviolet Germicidal Irradiation (UVGI) can be expected to mitigate the spread of Tuberculosis.
This report describes the distribution of TB cases among the population of California and the demographic and clinical characteristics of TB cases in 2003. It presents the risk factors for TB, drug resistance, treatment outcomes of the reporting jurisdictions in California, and recent trends.
This brochure discusses TB and its relationship to HIV/AIDS.
This brochure discusses the basic facts about tuberculosis including TB transmission, symptoms, and testing; and explains the difference between latent TB infection and active TB disease.
This brochure discusses the basic facts about tuberculosis including TB transmission, symptoms, and testing; and explains the difference between latent TB infection and active TB disease.
This brochure provides information about TB clinic locations and hours of operation in San Diego area.
This brochure provides information about TB clinic locations and hours of operation in San Diego area.